GRAY SUSANNAH
Insider CIK 1833453 · ANAB Director · TBPH Director · FDMT Director · MORF Director · APR Director · MRVI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 23,576 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 24,258 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 13,398 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 32,666 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 22,044 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 6,009 | — | $0 | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 42,137 | — | $0 | 6,009 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 13,398 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 24,258 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 23,576 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 22,044 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer deriv | 2026-09-23 | 2026-09-24 | 32,666 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 6,009 | — | — | 0 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | D To issuer | 2026-09-23 | 2026-09-24 | 42,137 | — | — | 6,009 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2026-06-17 | 2026-06-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2026-06-12 | 2026-06-16 | 13,398 | — | $0 | 13,398 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2026-06-12 | 2026-06-16 | 6,009 | — | $0 | 48,146 | SEC↗ |
| MRVI MARAVAI LIFESCIENCES HOLDI | A Award | 2026-05-26 | 2026-05-28 | 46,293 | — | $0 | 216,200 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-04-27 | 2026-04-29 | 11,250 | — | $0 | 11,250 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2025-06-17 | 2025-06-20 | 22,500 | — | $0 | 22,500 | SEC↗ |
| MRVI MARAVAI LIFESCIENCES HOLDI | A Award | 2025-06-16 | 2025-06-18 | 89,139 | $2.16 | $192.5K | 169,907 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2025-05-19 | 2025-05-21 | 24,258 | — | $0 | 24,258 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2025-05-19 | 2025-05-21 | 10,649 | — | $0 | 42,137 | SEC↗ |
| MORF Morphic Holding, Inc. | D To issuer deriv | 2024-08-16 | 2024-08-20 | 17,550 | — | $0 | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | D To issuer deriv | 2024-08-16 | 2024-08-20 | 12,535 | — | $0 | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | D To issuer deriv | 2024-08-16 | 2024-08-20 | 23,168 | — | $0 | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | D To issuer deriv | 2024-08-16 | 2024-08-20 | 18,111 | — | $0 | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2024-06-04 | 2024-06-05 | 23,168 | — | $0 | 23,168 | SEC↗ |
| MRVI MARAVAI LIFESCIENCES HOLDI | A Award | 2024-05-23 | 2024-05-24 | 20,645 | $10.78 | $222.6K | 80,768 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2024-05-21 | 2024-05-23 | 22,500 | — | $0 | 22,500 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2024-05-08 | 2024-05-10 | 23,576 | — | $0 | 23,576 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2024-05-08 | 2024-05-10 | 10,537 | — | $0 | 31,488 | SEC↗ |
| MRVI MARAVAI LIFESCIENCES HOLDI | A Award | 2023-07-17 | 2023-07-19 | 24,000 | — | $0 | 60,123 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2023-06-01 | 2023-06-02 | 12,535 | — | $0 | 12,535 | SEC↗ |
| FMDT 4D Molecular Therapeutics, | A Award deriv | 2023-05-23 | 2023-05-25 | 22,500 | — | $0 | 22,500 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2023-05-02 | 2023-05-04 | 22,044 | — | $0 | 22,044 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2023-05-02 | 2023-05-04 | 9,132 | — | $0 | 20,951 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2023-02-26 | 2023-02-28 | 28,000 | — | $0 | 28,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2023-02-26 | 2023-02-28 | 4,666 | — | $0 | 4,666 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2023-02-26 | 2023-02-28 | 10,131 | — | $0 | 10,131 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2023-02-26 | 2023-02-28 | 1,688 | — | $0 | 11,819 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 17,550 | — | $0 | 17,550 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2022-05-23 | 2022-05-25 | 22,500 | — | $0 | 22,500 | SEC↗ |
| APR Apria, Inc. | D To issuer deriv | 2022-03-29 | 2022-03-29 | 5,059 | $37.50 | $189.7K | 0 | SEC↗ |
| MRVI MARAVAI LIFESCIENCES HOLDI | A Award | 2021-11-19 | 2021-11-23 | 4,271 | — | $0 | 36,123 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2021-06-16 | 2022-04-29 | 0 | — | $0 | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 12,000 | — | $0 | 12,000 | SEC↗ |
| APR Apria, Inc. | A Award deriv | 2021-06-10 | 2021-06-14 | 5,059 | — | $0 | 5,059 | SEC↗ |
| FDMT 4D Molecular Therapeutics | A Award deriv | 2021-05-17 | 2021-05-19 | 22,500 | — | $0 | 22,500 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2021-04-27 | 2022-04-29 | 18,111 | — | $0 | 18,111 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2021-04-27 | 2021-04-29 | 24,000 | — | $0 | 24,000 | SEC↗ |
| MRVI MARAVAI LIFESCIENCES HOLDI | P Buy | 2020-11-24 | 2020-11-25 | 20,000 | $27.00 | $540.0K | 31,852 | SEC↗ |
| MRVI MARAVAI LIFESCIENCES HOLDI | A Award | 2020-11-19 | 2020-11-23 | 11,852 | — | $0 | 11,852 | SEC↗ |